Oscar Health (NYSE:OSCR) Stock Price Down 7.2% – Should You Sell?

Oscar Health, Inc. (NYSE:OSCR)’s share price traded down 7.2% on Friday. The stock traded as low as $31.20 and last traded at $30.9260. Approximately 2,083,722 shares traded hands during trading, a decline of 69% from the average daily volume of 6,762,301 shares. The stock had previously closed at $33.32.

Wall Street Analysts Forecast Growth

OSCR has been the topic of a number of research analyst reports. Wells Fargo & Company increased their price objective on shares of Oscar Health from $20.00 to $27.00 and gave the company an “equal weight” rating in a research note on Thursday, August 13th. Weiss Ratings upgraded shares of Oscar Health from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, October 8th. UBS Group increased their target price on shares of Oscar Health from $26.00 to $36.00 and gave the stock a “neutral” rating in a report on Monday, October 12th. Barclays lifted their price target on shares of Oscar Health from $39.00 to $49.00 and gave the company an “overweight” rating in a report on Thursday, September 17th. Finally, Zacks Research raised shares of Oscar Health from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 6th. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $34.90.

Oscar Health Trading Down 7.0%

The firm has a market cap of $9.56 billion, a P/E ratio of 22.05, a P/E/G ratio of 0.37 and a beta of 2.47. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.09 and a current ratio of 1.09. The firm has a fifty day moving average of $31.82 and a 200-day moving average of $27.32.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings data on Thursday, August 6th. The company reported $1.10 EPS for the quarter, topping analysts’ consensus estimates of $0.40 by $0.70. Oscar Health had a return on equity of 38.45% and a net margin of 3.60%. The firm had revenue of $4.88 billion during the quarter, compared to the consensus estimate of $4.73 billion. During the same period in the prior year, the business earned ($0.89) EPS. The firm’s revenue was up 70.4% on a year-over-year basis. Equities research analysts forecast that Oscar Health, Inc. will post 1.83 earnings per share for the current year.

Insider Buying and Selling at Oscar Health

In related news, CFO Richard Blackley sold 28,869 shares of Oscar Health stock in a transaction dated Thursday, September 3rd. The shares were sold at an average price of $31.45, for a total value of $907,930.05. Following the sale, the chief financial officer directly owned 1,046,108 shares in the company, valued at $32,900,096.60. This trade represents a 2.69% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Vanessa Wittman sold 25,000 shares of the business’s stock in a transaction dated Friday, September 18th. The shares were sold at an average price of $32.24, for a total transaction of $806,000.00. Following the transaction, the director directly owned 112,121 shares of the company’s stock, valued at $3,614,781.04. The trade was a 18.23% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 874,451 shares of company stock valued at $26,761,671. Corporate insiders own 22.64% of the company’s stock.

Institutional Investors Weigh In On Oscar Health

A number of hedge funds have recently made changes to their positions in the business. Tidal Investments LLC acquired a new stake in Oscar Health in the 2nd quarter valued at approximately $2,240,000. Convergence Investment Partners LLC acquired a new stake in Oscar Health in the first quarter worth about $1,208,000. Fideuram Intesa Sanpaolo Private Banking S.P.A. bought a new stake in shares of Oscar Health during the 1st quarter worth about $1,297,000. Wellington Management Group LLP lifted its stake in shares of Oscar Health by 65.6% in the 2nd quarter. Wellington Management Group LLP now owns 603,675 shares of the company’s stock worth $17,217,000 after acquiring an additional 239,109 shares during the period. Finally, Genesee Capital Advisors LLC lifted its stake in shares of Oscar Health by 227.8% in the 3rd quarter. Genesee Capital Advisors LLC now owns 44,338 shares of the company’s stock worth $1,367,000 after acquiring an additional 30,814 shares during the period. Institutional investors own 75.70% of the company’s stock.

Oscar Health Company Profile

Oscar Health, Inc is a technology-focused health insurance company that provides health plans and related services in the United States. The company primarily serves individuals and families purchasing coverage through the Affordable Care Act’s health insurance marketplace, as well as small businesses and their employees.

Oscar combines health insurance products with digital tools designed to help members manage their care. Its services include online enrollment, virtual care, provider search and appointment support, care navigation, claims and benefits information, and member engagement through web and mobile applications.